Circulating DPP3 limits efficacy of angiotensin II infusion in septic shock

Dirk van Lier; Karine Santos; Oliver Hartmann; Matthijs Kox; Peter Pickkers

PMC · DOI:10.1186/s13054-026-05971-5·March 25, 2026

Circulating DPP3 limits efficacy of angiotensin II infusion in septic shock

Dirk van Lier, Karine Santos, Oliver Hartmann, Matthijs Kox, Peter Pickkers

PDF

Open Access

Abstract

Linked entities

Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.

Genes4

REN AP2B1 AGT DPP3

Proteins4

Species1

Homo sapiens(human · species)

Chemicals4

Norepinephrine 4Teen4 Procizumab Catecholamine

Diseases6

septic vasoplegic syndrome -II CRVS organ failure sepsis

Figures1

Click any figure to enlarge with its caption.

Peer Reviews

No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.

Videos

No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.

Taxonomy

TopicsS100 Proteins and Annexins · Diabetes Treatment and Management · Sepsis Diagnosis and Treatment